Mar 30, 2022 04:05PM

May 13, 2021 04:05PM

Mar 16, 2021 09:30AM

Mar 15, 2021 09:29AM

Mar 12, 2020 04:05PM

Dec 30, 2019 08:05AM

Dec 30, 2019 08:05AM Savara Granted Breakthrough Therapy Designation for Molgradex for the Treatment of Autoimmune Pulmonary Alveolar Proteinosis (aPAP)

Dec 20, 2019 11:53AM

Dec 20, 2019 11:51AM

Dec 3, 2019 04:12PM

Dec 3, 2019 04:05PM

Nov 18, 2019 08:05AM

Nov 7, 2019 04:05PM

Oct 2, 2019 09:19AM Pre-Open Movers 10/02: (VHC) (AIMT) (LEN) Higher; (SVRA) (UNFI) (AYI) Lower (more...)

Oct 2, 2019 08:08AM

Oct 2, 2019 08:02AM

Sep 18, 2019 04:15PM

Aug 8, 2019 04:02PM

Aug 1, 2019 08:02AM

Jul 31, 2019 08:02AM

Jun 13, 2019 04:02PM Savara to Present at the JMP Securities Life Sciences Conference

Jun 12, 2019 04:04PM

Jun 12, 2019 04:02PM

May 9, 2019 04:02PM

May 6, 2019 08:11AM

May 6, 2019 08:02AM

May 2, 2019 08:02AM

Apr 2, 2019 08:00AM Savara to Present at the H.C. Wainwright Global Life Sciences Conference in London

Apr 1, 2019 08:12AM

Apr 1, 2019 08:00AM

Mar 13, 2019 04:02PM

Mar 6, 2019 08:00AM

Mar 4, 2019 08:00AM

Feb 6, 2019 08:06AM

Feb 6, 2019 08:00AM Savara Provides Update on IMPALA and AVAIL Pivotal Clinical Studies

Feb 6, 2019 08:00AM

Dec 19, 2018 08:03AM

Dec 19, 2018 08:00AM

Dec 19, 2018 08:00AM

Nov 16, 2018 08:00AM

Nov 16, 2018 08:00AM

Nov 7, 2018 04:02PM Savara Reports Third Quarter 2018 Financial Results and Provides Business Update

Nov 7, 2018 04:02PM

Nov 1, 2018 08:00AM

Nov 1, 2018 08:00AM

Oct 31, 2018 08:06AM

Oct 31, 2018 08:00AM

Oct 31, 2018 08:00AM

Oct 15, 2018 08:02AM Savara (SVRA) Reports Completes Enrollment in Pivotal Molgradex Impala Clinical Study for the Treatment of aPAP

Oct 15, 2018 08:00AM

1,155,229 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All